Ipragliflozin–Insulin Combination Reduces Severe Hypoglycemia With No Rise in Diabetic Ketoacidosis Read more about Ipragliflozin–Insulin Combination Reduces Severe Hypoglycemia With No Rise in Diabetic Ketoacidosis
Type 2 Diabetes and Inflammatory Bowel Disease Demonstrate a Bidirectional Association Read more about Type 2 Diabetes and Inflammatory Bowel Disease Demonstrate a Bidirectional Association
Oral PCSK9 Inhibitors Substantially Reduce LDL-C in Hypercholesterolemia Tags TPHT_others Read more about Oral PCSK9 Inhibitors Substantially Reduce LDL-C in Hypercholesterolemia
Oral Semaglutide Lowers Mortality and Major Cardiovascular Events in High-Risk T2DM Tags TPHT_others Read more about Oral Semaglutide Lowers Mortality and Major Cardiovascular Events in High-Risk T2DM
Routine Dipstick Protein Testing Identifies High-Risk HFrEF Phenotypes Tags Renal Disease Read more about Routine Dipstick Protein Testing Identifies High-Risk HFrEF Phenotypes
Tirzepatide Achieves Robust 10-Year Risk Reduction in Obesity and Prediabetes Read more about Tirzepatide Achieves Robust 10-Year Risk Reduction in Obesity and Prediabetes
Nighttime Hypoglycaemia and Diabetes Duration Impair Navigation Skills in Adolescents Tags Hypoglycemia Read more about Nighttime Hypoglycaemia and Diabetes Duration Impair Navigation Skills in Adolescents
Serum Arginase1 Reflects Early Oxidative Stress in Type 2 Diabetes Read more about Serum Arginase1 Reflects Early Oxidative Stress in Type 2 Diabetes
SGLT2 inhibitors linked to lower one-year mortality in LVAD patients Tags TPHT_others Read more about SGLT2 inhibitors linked to lower one-year mortality in LVAD patients
Finerenone Offers Improved Safety and Outcomes Over Spironolactone in HFpEF Tags TPHT_others Read more about Finerenone Offers Improved Safety and Outcomes Over Spironolactone in HFpEF